| Literature DB >> 28794492 |
Pinglin Li1,2, Xiaoling Liu1,2, Hongyan Zhu1,2, Xuli Tang3, Xuefeng Shi1,2, Yonghong Liu4, Guoqiang Li5,6.
Abstract
Three new guaiazulene alkaloids muriceidines A-C (1-3) and one new bis-sesquiterpene muriceidone A (4), were isolated from the South China Sea gorgonian Muriceides collaris. Muriceidines are the first examples structurally architected by guaiazulene coupling with an inner-salt Δ 1-pipecolic acid via a unique sp2 methine-bridged linkage, and the bis-sesquiterpene was comprised by a guaiazulene and a indene units linked through a unprecedented carbon-carbon σ-bond between the high steric bridgehead carbon C-10 of guaiazulene moiety and C-2' of indene moiety. The chiral compounds 2-4 were obtained initially as racemates and further separated by chiral HPLC methods. The inner-salt structures of 1-3 and absolute configurations of 2-4 were fully elucidated by calculated 13C NMR, ECD and OR with quantum chemical calculation methods. Compound 1 showed cytotoxicity against K562 cell lines with IC50 value of 8.4 μM and antifouling activity against the larvae of the barnacle Balanus albicostatus with EC50 value of 11.9 μg/mL and potent therapeutic index (LC50/EC50 = 3.66). Also the racemic (±)-3 showed cytotoxicities against both HL-60 and K562 cell lines with IC50 values of 2.2 and 3.7 μM, respectively. A semisynthetic trial was performed to validate the proposed biosynthetic hypotheses.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28794492 PMCID: PMC5550455 DOI: 10.1038/s41598-017-08100-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structures of 1–6 from Gorgonian Muriceides collaris.
NMR Data for muriceidines A–C (1–3) (δ in ppm).
| no. |
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
| 1 | 128.2, C | 131.5, C | 128.7, C | |||
| 2 | 139.0, CH | 7.81 (s) | 141.7, CH | 8.51 (s) | 140.0, CH | 7.88 (s) |
| 3 | 123.5, C | 124.2, C | 123.0, C | |||
| 4 | 149.3, C | 149.9, C | 149.3, C | |||
| 5 | 133.4, CH | 7.33 (d, 11.0) | 136.3, CH | 7.58 (d, 10.4) | 133.8, CH | 7.36 (d, 10.4) |
| 6 | 137.1, CH | 7.51 (dd, 11.0, 2.2) | 138.8, CH | 7.75 (d, 10.4) | 137.2, CH | 7.54 (d, 10.4) |
| 7 | 146.8, C | 150.9, C | 147.3, C | |||
| 8 | 134.8, CH | 8.17 (d, 2.2) | 136.2, CH | 8.35 (br s) | 134.8, CH | 8.18 (s) |
| 9 | 142.8, C | 146.5, C | 143.8, C | |||
| 10 | 141.0, C | 143.9, C | 141.5, C | |||
| 11 | 38.2, CH | 3.11 (dq, 6.6, 6.6) | 39.3, CH | 3.21 (dq, 6.6, 6.6) | 38.2, CH | 3.12 (dq, 6.6, 6.6) |
| 12 | 24.5, CH3 | 1.37 (d, 6.6) | 24.6, CH3 | 1.40 (d, 6.6) | 24.6, CH3 | 1.37 (d, 6.6) |
| 13 | 24.5, CH3 | 1.37 (d, 6.6) | 24.6, CH3 | 1.40 (d, 6.6) | 24.6, CH3 | 1.37 (d, 6.6) |
| 14 | 13.3, CH3 | 2.58 (s) | 13.2, CH3 | 2.62 (s) | 13.4, CH3 | 2.59 (s) |
| 15 | 29.7, CH3 | 3.17 (s) | 29.8, CH3 | 3.13 (s) | 29.8, CH3 | 3.18 (s) |
| 16 | 149.4, CH | 9.56 (s) | 151.4, CH | 9.16 (s) | 152.8, CH | 9.90 (s) |
| 2′ | 172.3, C | 173.1, C | 170.5, C | |||
| 3′ | 118.0, C | 117.9, C | 117.5, C | |||
| 4′ | 24.7, CH2 | 2.95 (t, 6.0) | 61.6, CH | 5.05 (s) | 69.7, CH | 4.69 (s) |
| 5′ | 20.4, CH2 | 2.03 (m) | 29.8, CH2 | 2.16 (br d, 13.8), 1.95 (t, 13.8) | 23.5, CH2 | 2.43 (br d, 14.3), 1.82 (m) |
| 6′ | 42.9, CH2 | 3.77 (t, 5.5) | 38.5, CH2 | 3.81 (m), 3.63 (dd, 15.0, 4.8) | 38.2, CH2 | 3.82 (br d, 7.7) |
| 7′ | 163.9, C | 167.2, C | 162.9, C | |||
| OMe | 54.3, CH3 | 3.45 (s) | ||||
aRecorded at 150 MHz in CDCl3.
bRecorded at 600 MHz in CDCl3.
cRecorded at 150 MHz in CD3OD.
dRecorded at 600 MHz in CD3OD.
Figure 2Structure elucidation of muriceidines A-C (1–3). (A) Key COSY, HMBC and NOESY correlations of 1. (B) Correlation of experimental chemical shifts and calculated isotropic shielding constants of compound 1 with the respective inner-salt (B-a) and non-ionized (B-b) structure. (C) Calculated and experimental ECD curves of compounds (+)-2 and (−)-2.
The calculated 13C NMR chemical shifts of compound 1.
| no. |
|
|
|
|
| no. |
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 128.2 | 135.0 | 128.5 | 132.0 | 127.3 | 12 | 24.5 | 25.9 | 22.4 | 25.9 | 22.0 |
| 2 | 139.0 | 145.1 | 138.3 | 144.5 | 139.7 | 13 | 24.5 | 25.8 | 22.3 | 25.9 | 21.9 |
| 3 | 123.5 | 130.1 | 123.7 | 128.8 | 124.2 | 14 | 13.3 | 15.2 | 11.9 | 14.8 | 10.9 |
| 4 | 149.3 | 160.7 | 153.4 | 158.5 | 153.7 | 15 | 29.7 | 32.7 | 29.0 | 32.1 | 28.0 |
| 5 | 133.4 | 140.4 | 133.7 | 135.3 | 130.6 | 16 | 149.4 | 160.1 | 152.9 | 145.2 | 140.5 |
| 6 | 137.1 | 145.5 | 138.7 | 143.1 | 138.4 | 2′ | 172.3 | 170.9 | 163.4 | 163.1 | 158.2 |
| 7 | 146.8 | 157.2 | 150.0 | 152.1 | 147.3 | 3′ | 118.0 | 123.8 | 117.6 | 126.8 | 122.2 |
| 8 | 134.8 | 140.7 | 134.0 | 140.9 | 136.2 | 4′ | 24.7 | 28.5 | 24.9 | 29.5 | 25.5 |
| 9 | 142.8 | 151.3 | 144.3 | 147.8 | 143.1 | 5′ | 20.4 | 24.4 | 20.9 | 25.5 | 21.6 |
| 10 | 141.0 | 150.3 | 143.3 | 146.2 | 141.4 | 6′ | 42.9 | 45.2 | 41.1 | 53.4 | 49.3 |
| 11 | 38.2 | 46.0 | 41.9 | 46.0 | 41.9 | 7′ | 163.9 | 165.4 | 158.1 | 172.3 | 167.4 |
: unscaled chemical shifts of inner salt structure relative to TMS at the same level of theory.
: calculated chemical shifts of inner salt structure after linear scaling.
: unscaled chemical shifts of non-ionized structure relative to TMS at the same level of theory.
: calculated chemical shifts of non-ionized structure after linear scaling.
1H and 13C NMR data for muriceidone A (4) in CDCl3.
| Position |
|
| Position |
|
|
|---|---|---|---|---|---|
| 1 | 167.3, C | 1′ | 76.7, C | ||
| 2 | 132.1, CH | 6.19 (s) | 2′ | 59.5, CH | 3.03 (s) |
| 3 | 206.4, C | 3′ | 202.3, C | ||
| 4 | 133.4, C | 4′ | 140.0, C | ||
| 5 | 124.3, CH | 6.26 (d, 6.6) | 5′ | 134.4, C | |
| 6 | 126.3, CH | 6.54 (d, 6.6) | 6′ | 194.6, CH | 10.61 (s) |
| 7 | 147.5, C | 7′ | 157.4, C | ||
| 8 | 117.1, CH | 6.44 (s) | 8′ | 118.7, CH | 7.49 (s) |
| 9 | 138.3, C | 9′ | 162.4, C | ||
| 10 | 55.7, C | 10′ | 129.3, C | ||
| 11 | 36.0, CH | 2.69 (dq, 6.6, 7.2) | 11′ | 29.6, CH | 3.59 (dq, 6.6, 6.6) |
| 12 | 23.0, CH3 | 1.13 (d, 6.6) | 12′ | 23.9, CH3 | 1.27 (d, 6.6) |
| 13 | 23.5, CH3 | 1.17 (d, 7.2) | 13′ | 24.0, CH3 | 1.30 (d, 6.6) |
| 14 | 15.1, CH3 | 2.31 (s) | 14′ | 28.4, CH3 | 1.87 (s) |
| 15 | 24.1, CH3 | 1.83 (s) | 15′ | 14.3, CH3 | 2.69 (s) |
| OH-3′ | 2.17 (br s) |
Recorded at 150 MHz. Recorded at 600 MHz.
Figure 3Structure elucidation of muriceidone A (4). (A) Key HMBC and NOESY correlations of 4. (B) Calculated and experimental ECD curves of compounds (+)-4 and (−)-4 in 10S,1′R,2′R/10R,1′S,2′S configuration. (C) Calculated and experimental ECD curves of compounds (+)-4 and (−)-4 in 10S,1′S,2′S/10R,1′R,2′R configuration.
Cytotoxic activities of compounds 1–4 (IC50 μM) with adramycin as positive control.
| compounds | A549 | HeLa | K562 | HL-60 |
|---|---|---|---|---|
|
| >100 | 17.9 | 8.4 | >100 |
|
| >100 | >100 | >100 | >100 |
| (+)- | >100 | >100 | >100 | >100 |
| (−)- | >100 | >100 | >100 | >100 |
|
| 82.7 | >100 | 3.7 | 2.2 |
| (+)- | >100 | 53.7 | 47.2 | 22.7 |
| (−)- | >100 | 53.2 | 53.2 | 5.1 |
|
| >100 | >100 | >100 | >100 |
| (+)- | >100 | 42.7 | 88.4 | 54.2 |
| (−)- | >100 | 40.0 | >100 | >100 |
| Adramycin | 0.6 | 0.6 | 0.2 | 0.3 |
Figure 4Biosynthetic pathway and semisynthetic procedure of the new compounds 1–3. (A) Proposed Biosynthetic Pathway for Compounds 1–3. (B) Semisynthetic procedure of muriceidine A (1).